Reacción exantematosa inducida por ziprasidona
Calvo Estopiñán, Pilar; Sanz Carrillo, Concepción; Alonso-Lej Torres, Jorge.
Psiquiatr. biol. (Ed. impr.)
; 15(5): 182-183, oct.-dic. 2008.
Artículo en Es | IBECS (España) | ID: ibc-68879
Documentos relacionados
Analysis of adverse drug events in patients with bipolar disorders using the Japanese Adverse Drug Event Report database.
Use of clozapine for resolving lamotrigine-induced skin lesions caused by schizophrenia treatment.
Antipsychotic-Induced Drug Rash With Eosinophilia and Systemic Symptoms Syndrome: A Case Report.
A High Plasma Lamotrigine Concentration at Week 2 as a Risk Factor for Lamotrigine-Related Rash.
COVID-19 and favipiravir induce cutaneous adverse reactions: a difficulty in clinical dermatology practice.
Desensitization protocol to lenalidomide: An effective and safe treatment modality for delayed hypersensitivity-induced rash in patients with multiple myeloma.
Symmetrical drug-related intertriginous and flexural exanthem due to oral risperidone.
Cutaneous eruptions from ibrutinib resembling epidermal growth factor receptor inhibitor-induced dermatologic adverse events.
Acute exanthemas: a prospective study of 98 adult patients with an emphasis on cytokinic and metagenomic investigation.
Atezolizumab-induced psoriasiform drug eruption successfully treated with ixekizumab: a case report and literature review.